Literature DB >> 1119316

Myopathy and neuropathy associated with osteomalacia.

J Skaria, B C Katiyar, T P Srivastava, B Dube.   

Abstract

Thirty unselected females with proven osteomalacia were evaluated clinically, electromyographically and histopathologically for muscle dysfunction. Clinical evidence of myopathy was found in all the patients except one; the electromyograms were abnormal in 25 of them, and histopathological abnormalities, although slight and nonspecific, were seen in all the 17 patients who underwent muscle biopsy. Electromyographic findings revealed a myopathic pattern as evidenced by a significant reduction in motor unit potential duration and amplitude, and an increased percentage polyphasicity as compared to the controls. There was a complete absence of denervation potentials. The histopathological abnormalities were nonspecific and slight, and consisted of fatty infiltration, interstitial fibrosis, sarcolemmal nuclear proliferation and variation in muscle fibre thickness. A statistically significant reduction in motor nerve conduction velocities of the ulnar and peroneal nerves was found. It was considered that this reduction in the velocities was due to subclinical neuropathy. Our data suggest that myopathy, neuropathy and osteomalacia in our patients are due to nutritional deficiencies of multiple vitamins.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1119316     DOI: 10.1111/j.1600-0404.1975.tb01358.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  25 in total

1.  Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations.

Authors:  S W Kim; N Hong; Y Rhee; Y-C Choi; H Y Shin; S M Kim
Journal:  Osteoporos Int       Date:  2018-04-05       Impact factor: 4.507

2.  Cross-sectional association between serum vitamin D concentration and walking speed measured at usual and fast pace among older women: the EPIDOS study.

Authors:  Cédric Annweiler; Anne-Marie Schott; Manuel Montero-Odasso; Gilles Berrut; Bruno Fantino; François R Herrmann; Olivier Beauchet
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

3.  Reversible muscle weakness in patients with vitamin D deficiency.

Authors:  K Ziambaras; S Dagogo-Jack
Journal:  West J Med       Date:  1997-12

4.  Recognizing the musculoskeletal manifestations of vitamin D deficiency.

Authors:  Andrea N Jones; Karen E Hansen
Journal:  J Musculoskelet Med       Date:  2009-10

5.  Osteomalacia induced peripheral neuropathy after obesity reduction surgery.

Authors:  Samhita Panda; Kapil Sharma
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

6.  Muscle weakness in intensive care patients: initial manifestation of vitamin D deficiency.

Authors:  J M Rimaniol; F J Authier; P Chariot
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

7.  Effects of vitamin d on muscle function and performance: a review of evidence from randomized controlled trials.

Authors:  Lars Rejnmark
Journal:  Ther Adv Chronic Dis       Date:  2011-01       Impact factor: 5.091

8.  Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.

Authors:  Astrid Fahrleitner; Harald Dobnig; Andrea Obernosterer; Ernst Pilger; Georg Leb; Kurt Weber; Stefan Kudlacek; Barbara M Obermayer-Pietsch
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

Review 9.  Fall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects.

Authors:  Cedric Annweiler; Manuel Montero-Odasso; Anne M Schott; Gilles Berrut; Bruno Fantino; Olivier Beauchet
Journal:  J Neuroeng Rehabil       Date:  2010-10-11       Impact factor: 4.262

Review 10.  Vitamin D-related changes in physical performance: a systematic review.

Authors:  C Annweiler; A M Schott; G Berrut; B Fantino; O Beauchet
Journal:  J Nutr Health Aging       Date:  2009-12       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.